Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
| Distributed by / for | RemedyRepack Inc. |
| NDC | 68180-0980-03 |
| Full product label | Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00 |
| Recalling firm | RemedyRepack Inc. |
| Distribution | Distributed to two direct accounts in PA and AK. |
| Quantity | 1,699 blister cards/30 tablets each |
| Recall initiated | 2022-09-15 |
| Report date | 2022-09-21 |
| Recall completed | 2022-11-16 |
| Recall number | D-1538-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Indiana PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗